Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia
NCT ID: NCT02213562
Last Updated: 2016-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2014-07-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Indian Gooseberry Extract (AMX160) in Hypercholesterolemia
NCT03479983
Improvement of Depression in Terminal Cancer Patients
NCT06785623
Culinary Spices in Metabolic Syndrome.
NCT06423248
Effects of Chamomile With L-theanine Beverage Among Young Women Experiencing Primary Dysmenorrhea
NCT07092878
A Multiple-Dose Research Study on Safety Evaluation of the GD Antrodia Camphorata in 30 Healthy Adult Subjects
NCT01007656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
200 mg CFO
200 mg of chrysanthemum flower oil
200 mg of chrysanthemum flower oil
300 mg CFO
300 mg of chrysanthemum flower oil
300 mg of chrysanthemum flower oil
400 mg CFO
400 mg of chrysanthemum flower oil
400 mg of chrysanthemum flower oil
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
200 mg of chrysanthemum flower oil
300 mg of chrysanthemum flower oil
400 mg of chrysanthemum flower oil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of gouty attack
* Taking drugs or functional food that may affect serum uric acid level
* Hypertention, hyperlipidemia, or diabetes millitus
* Participation in any clinical trial within 90 days of the commencement of the trial
* Renal or hepatic dysfunction
* Heart disease
* History of severe disease and/or major surgery
30 Years
60 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaneka Corporation
INDUSTRY
Hiroshima University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fumiko Higashikawa
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fumiko Higashikawa, PhD
Role: PRINCIPAL_INVESTIGATOR
Hiroshima University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hiroshima University
Hiroshima, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
eki-997
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.